Study reveals how SARS-CoV-2 hijacks lung cells to drive COVID-19 severity

Researchers identified how SARS-CoV-2 targets and manipulates specific lung cells, using innovative techniques to trace the virus’s impact on the cells’ gene expression, revealing insights into early COVID-19 pathogenesis.

Expanded Treatment Options for Primary Biliary Cholangitis Leave Open Questions

The approval of ursodeoxycholic acid (UDCA) for primary biliary cholangitis (PBC) in 1997 marked a pivotal turning point in management of the condition, substantially reducing

December 1, 2024

Physical activity may help alleviate pain intensity for cancer survivors

People who have had cancer often experience ongoing pain, but a new study reveals that being physically active may help lessen its intensity.

February 12, 2024

Neumora’s antidepressant stumbles in first Phase 3 trial readout

A new depression treatment developed by startup Neumora Therapeutics failed in a Phase 3 clinical trial — the company’s first late-stage readout. The drug, navacaprant,

January 2, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.